05203326 is referenced by 562 patents and cites 6 patents.

An antiarrhythmia pacemaker detects the occurrence of an abnormal condition of a patient's heart and, in response, delivers an antiarrhythmia therapy to the patient which includes two components, electrical stimulation of the heart and electrical stimulation of nerves or ganglia in the autonomic nervous system. The antiarrhythmia pacemaker controls electrical stimulation of the heart in terms of timing, frequency, amplitude, duration and other operational parameters, to provide such pacing therapies as antitachycardia pacing, cardioversion and defibrillation. A nerve stimulation electrode, which is driven by a nerve fiber pulse stimulator, stimulates preselected nerve fibers within the patient's autonomic nervous system. An arrhythmia therapy control responds to the detection and confirmation of an abnormal heart condition by controlling and coordinating the heart pulse stimulator and the nerve fiber stimulator to direct performance of a combined heart and nerve stimulation therapy.

Title
Antiarrhythmia pacer using antiarrhythmia pacing and autonomic nerve stimulation therapy
Application Number
7/809978
Publication Number
5203326
Application Date
December 18, 1991
Publication Date
April 20, 1993
Inventor
Kenneth A Collins
Neutral Bay
AU
Agent
Gottlieb Rackman & Reisman
Assignee
Telectronics Pacing Systems
CO, US
IPC
A61N 1/362
View Original Source